甘諮詢(000779.SZ):2079萬元競得蘭州新區一宗科研用地
格隆匯1月27日丨甘諮詢(000779.SZ)公佈,公司於2020年12月16日召開第七屆董事會第十八次會議,審議通過了《關於公司擬在蘭州新區購置檢測科研用地的議案》,公司擬以自有資金約2300萬元購買蘭州新區檢測園區80畝土地用於籌建檢測科研基地。
2020年12月21日,公司參與蘭州新區LXQ2020076C號國有建設用地使用權掛牌競拍交易。近日,公司與出讓人蘭州新區自然資源局簽訂了《國有建設用地使用權出讓合同》。
土地位置:蘭州新區緯十八路以南、經十路以東;土地面積:49492.30平方米;土地性質:科研用地;出讓年限:40年;土地價格:2079萬元人民幣(不含税費)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.